(Q53146292)

11 May 2018

title

Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden. (English)

1 reference

11 May 2018

0 references

0 references

1 reference

1 reference

6

1 reference

11 May 2018

Olof Johnell

4

object named as

Olof Johnell

1 reference

11 May 2018

author name string

Oskar Ström

1

1 reference

11 May 2018

Fredrik Borgstrom

2

1 reference

11 May 2018

Niklas Zethraeus

3

1 reference

11 May 2018

Lars Lidgren

5

1 reference

11 May 2018

Olle Svensson

7

1 reference

11 May 2018

Peter Abdon

8

1 reference

11 May 2018

Ewald Ornstein

9

1 reference

11 May 2018

Leif Ceder

10

1 reference

11 May 2018

Karl Goran Thorngren

11

1 reference

11 May 2018

Ingemar Sernbo

12

1 reference

11 May 2018

Bengt Jonsson

13

1 reference

11 May 2018

publication date

1 April 2008

1 reference

11 May 2018

published in

Acta Orthopaedica

1 reference

11 May 2018

volume

79

1 reference

11 May 2018

issue

2

1 reference

11 May 2018

page(s)

269-280

1 reference

11 May 2018

Cost effectiveness of alendronate for the treatment of male osteoporosis in Sweden

cites work

1 reference

https://api.crossref.org/works/10.1080%2F17453670710015094

An economic evaluation of strontium ranelate in the treatment of osteoporosis in a Swedish setting: based on the results of the SOTI and TROPOS trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17453670710015094

Costs and quality of life associated with osteoporosis-related fractures in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17453670710015094

The societal burden of osteoporosis in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17453670710015094

A systematic review of health state utility values for osteoporosis-related conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17453670710015094

Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17453670710015094

EuroQol: the current state of play

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17453670710015094

Swedish population health-related quality of life results using the EQ-5D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17453670710015094

The cost of treating osteoporotic fractures in the United Kingdom female population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17453670710015094

Long-term risk of osteoporotic fracture in Malmö.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17453670710015094

Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17453670710015094

Cost-equivalence of different osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17453670710015094

Cost analysis of hip fracture treatment among the elderly for the public health services: a 1-year prospective study in 106 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17453670710015094

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17453670710015094

Direct costs of hip fractures in patients over 60 years of age in Belgium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17453670710015094

Economic implications of hip fracture: health service use, institutional care and cost in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17453670710015094

Estimating the Costs of Hip Fracture and Potential Savings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17453670710015094

10.1080/17453670710015094

21 January 2018

Identifiers

DOI

1 reference

11 May 2018

PubMed ID

18484255

1 reference

11 May 2018